[HTML][HTML] Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process

A Singh, V Upadhyay, AK Upadhyay, SM Singh… - Microbial cell …, 2015 - Springer
Formation of inclusion bodies in bacterial hosts poses a major challenge for large scale
recovery of bioactive proteins. The process of obtaining bioactive protein from inclusion …

Bacterial inclusion bodies: a treasure trove of bioactive proteins

P Singhvi, A Saneja, S Srichandan, AK Panda - Trends in Biotechnology, 2020 - cell.com
Recombinant proteins expressed as bacterial inclusion bodies (IBs) are now receiving
tremendous attention for many diverse applications in the areas of industrial and medical …

Bacterial inclusion bodies are industrially exploitable amyloids

A De Marco, N Ferrer-Miralles… - FEMS microbiology …, 2019 - academic.oup.com
Understanding the structure, functionalities and biology of functional amyloids is an issue of
emerging interest. Inclusion bodies, namely protein clusters formed in recombinant bacteria …

Microbial production, molecular modification, and practical application of L-asparaginase: A review

Y Wang, W Xu, H Wu, W Zhang, C Guang… - International Journal of …, 2021 - Elsevier
Abstract L-Asparaginase (L-ASNase, EC 3.5. 1.1), an antitumor drug for acute lymphoblastic
leukemia (ALL) therapy, is widely used in the clinical field. Similarly, L-ASNase is also a …

Catalytically-active inclusion bodies—Carrier-free protein immobilizates for application in biotechnology and biomedicine

U Krauss, VD Jäger, M Diener, M Pohl… - Journal of biotechnology, 2017 - Elsevier
Bacterial inclusion bodies (IBs) consist of unfolded protein aggregates and represent
inactive waste products often accumulating during heterologous overexpression of …

[HTML][HTML] Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process

A Sarker, AS Rathore, RD Gupta - Microbial Cell Factories, 2019 - Springer
Background The production of therapeutically active single chain variable fragment (scFv)
antibody is still challenging in E. coli due to the aggregation propensity of recombinant …

Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood …

TA Costa-Silva, IM Costa, HP Biasoto, GM Lima… - Blood Reviews, 2020 - Elsevier
L-asparaginase is an enzyme used as a biopharmaceutical to treat acute lymphoblastic
leukemia. Several adverse effects have been related to L-asparaginase use, so the scientific …

Glutaminase free L-asparaginase from Vibrio cholerae: heterologous expression, purification and biochemical characterization

R Radha, N Arumugam, SN Gummadi - International journal of biological …, 2018 - Elsevier
Abstract l-asparaginase is used as a pivotal agent in treatment of lympho proliferative
disorders and holds an excessive demand for food processing aids. Most of the l …

Molecular cloning, structural modeling and production of recombinant Aspergillus terreus L. asparaginase in Escherichia coli

H Saeed, H Ali, H Soudan, A Embaby… - International journal of …, 2018 - Elsevier
Abstract l-Asparaginase (EC 3.5. 1.1) is an important medical enzyme that catalysis the
hydrolysis of l-asparagine to aspartic acid and ammonium. For over four decades l …

[HTML][HTML] Recombinant expression of insoluble enzymes in Escherichia coli: a systematic review of experimental design and its manufacturing implications

S Mital, G Christie, D Dikicioglu - Microbial cell factories, 2021 - Springer
Recombinant enzyme expression in Escherichia coli is one of the most popular methods to
produce bulk concentrations of protein product. However, this method is often limited by the …